scholarly journals Mobilizing Global Business for a Healthier World

2016 ◽  
Vol 3 (2) ◽  
pp. 95
Author(s):  
Maria L. Nathan

GBCHealth (formerly the Global Business Coalition) has sought to apply the unique skills and expertise of the for profit world in the fight against HIV/AIDS, Malaria, TB, and other global health problems. Founded in 2001, GBCHealth is dedicated to “mobilizing business for a healthier world.” The alliance has rapidly grown from 17 to 220-plus international companies headquartered in over 30 different countries and representing all parts of the world; different workforces, industries, and geographical regions. A sharper focus is given to this analysis of GBCHealth’s within and cross-sector initiatives and accomplishments with use of an inter-organizational theory-based framework. This commitment by GBCHealth and alliance partners is a hopeful act of social responsibility that represents awareness of correlated fates as well as good business sense.


Corporate Social Responsibility has become a mainstream global business strategy in recent years and a large number of firms in the world issue numerous activities as a part of it. India is one of the first among few countries in the world to have a CSR act and the first to bring about legislation to implement CSR activities.The Government of India has made two significant interventions in the field of CSR-- in 2010, it made compulsory for public as well as private enterprises to spend 2 to 5 percent of their net profit on CSR; and it amended the Companies Act, 1956 that made compulsory provision for CSR under Section 135 in 2013. In this context this article is an attempt to discuss the progress in CSR initiatives in India over the years.



2021 ◽  
Author(s):  
Leigh Foran ◽  

HIV/AIDS, tuberculosis (TB), and malaria are considered the “big three” infectious diseases in global health. These illnesses alone account for nearly 3 million deaths every year, ravaging communities and countries around the world (National Center for Biotechnology Information, 2021). While this number alone is staggering, it is even more notable to observe exactly who is getting sick from these diseases. 95% of all AIDS victims, 98% of the world’s TB cases, and over 90% of the deaths from Malaria occurred in developing countries (National Center for Biotechnology Information, 2021).



2019 ◽  
Vol 3 (1) ◽  
pp. 55
Author(s):  
Ambrose Kipruto Chepkwei

Purpose: To establish corporate social responsibility strategy implementation globally.Methodology: This paper employed literature study, which is descriptive in nature as based on a review of existing literature within (journals, conference reports and websites) in regard to corporate social responsibility among various countries of the world. The researcher surveyed randomly existing research on corporate social responsibility strategy implementation in fifteen (15) countries within five (5) continents of the world with the sole objective to establish corporate social responsibility strategy implementation globally.Findings: In the global business set up today, clients are more informed about their rights and obligations. Corporate social responsibility strategy has greatly contributed to the success of various corporate institutions including financial institutions in the western world. Corporate social responsibility strategy is considered as an important instrument that pushes the competitive advantages, the creativity and innovation, improves business reputation to the society with the employees, furniture, state institutions and non governmental organization.Unique contribution to theory, practice and policy: Socially responsible companies can provide a better environment, a better quality of life and a more desirable community, corporate social reponsibility results in less government regulation while social reponsibility benefits long term stock prices as the market deems socially reponsible firms less risk.



2018 ◽  
Vol 1 (4) ◽  
Author(s):  
Margaret A. Winker ◽  
Lorraine E. Ferris ◽  
And the World Association of Medical Editors (WAME)

No abstract available. Editor’s note: The World Association of Medical Editors (WAME) is a voluntary global organization of medical journal editors, who are uniquely positioned to define the critical role that editors have to play in promoting global health. In its 20 years of existence, WAME has sought to facilitate worldwide cooperation and communication among editors of peer-reviewed medical journals, improve editorial standards, and promote professionalism in medical journal editing. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide. What follows is a formal statement of the rational underlying and guiding that responsibility.





Author(s):  
Susan M. Reverby

As Berkman battled a variety of cancers over the first years of 2000s, he also continued his global health work on HIV/AIDS. Whether it was a demonstration at the United Nations to demand global treatment or training programs for the Clinton Foundation in the Dominican Republic or courses for students at Columbia, he used his knowledge and skills around the world. He had become a global health “elder” whose ideas and support mattered to another generation. The cancers he had fought through stem cell operations were finally more than his body to fight and he died in June 2009.



2020 ◽  
Author(s):  
Henry Asante Antwi

Abstract BackgroundGlobal health crisis continues to drive the dynamics of corporate social responsibility across industries with self-perpetuating momentum. From a historical point of view, more than a century of immense corporate fecundity has formed the ecological conditions and shaped current understanding of the effect of global health on CSR. The HIV-AIDS, the Opiod, the environmental health, obesity and many other health crises have become a synergistic platform to enhance corporate offer and competitiveness through voluntary support and care for victims. This review therefore revisits the core issues in global health that continues to drive CSR across industries. It seek to establish the driving dynamics of healthcare in CSR engagement, identify its contribution to theory and practice and predict the future pattern as corporate enterprises navigate new CSR strategies through the epochal challenges presented by COVID-19MethodThe procedures and set of activities outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart was used to carry out the systematic review.ResultsThe analysis has shown that from time immemorial, global health has played a major role in the development and implementation of CSR among enterprises. The HIV-AIDS pandemic, the environmental health crises are two dominant global health crisis that have shaped and continue to drive CSR activities in numerous work places but COVID-19 presents a deeper challenge for enterprise. These diseases are capable of self-mobilising advocates at the international level, have a grabbing value that reaches the corridors of power in international humanitarian organisations and multinational enterprises.ConclusionsThe impact of the novel coronavirus (COVID-19) on CSR is predicted to be monumental and uncommon. The call for a radical overhaul of health and safety measures in enterprises is now urgent than ever before. There is a moral obligation for enterprises to reform current risk assessments and collaborate more deeply with state agencies to invest in the health and safety inspections at the world place.



Sign in / Sign up

Export Citation Format

Share Document